Skip to content
Open access

Elucidation of putative key genes involved in triple-negative breast cancer progression

Aug 2026 · Bioinformation · 0 citations

TL;DR

Gene ontology and KEGG enrichment analyses were performed to identify DEG-regulated biological functions and pathways and the PPI network showed six hub genes: CCND1, CDH1, ESR1, FN1, IL6 and PPARG as the top key genes.

Abstract

The molecular basis of TNBC development is poorly understood. Therefore, it is of interest to identify key genes and pathways involved in TNBC development and progression using a systems biology approach, followed by experimental validation. Gene ontology and KEGG enrichment analyses were performed to identify DEG-regulated biological functions and pathways; a PPI network was constructed using the STRING online database. The expression and prognostic value of the hub genes were validated by TCGA survival analysis, resulting in the identification of 727 DEGs (473 downregulated and 254 upregulated) in TNBC samples. The GO and KEGG analyses indicated that the DEGs were mainly related to cell adhesion and tumorigenesis and the PPI network showed six hub genes: CCND1, CDH1, ESR1, FN1, IL6 and PPARG as the top key genes. These were validated by real-time PCR in the TNBC cell line using a non-TNBC cell line as a calibrator and the obtained results were in accordance with the bioinformatics data

Read PDF

Similar papers

2026

Identification of key genes and pathways involved in trastuzumab resistance in HER2-positive gastric cancer through integrative bioinformatics analysis

This study provides a hypothesis-generating framework for future biomarker-guided combination strategies, which requires validation in HER2-positive cohorts and experimental models.

Feng Wang, N. Mottaghi-Dastjerdi, Fatma Altameemi et al. · 0 citations
Open access Sep 2026

In silico Identification of Key Genes and Repurposable Drugs for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a highly aggressive and treatment-resistant subtype, lacking HER2, progesterone, and estrogen receptors. Systemic chemotherapy remains the primary treatment due to the absence of molecular targets, often leading to poor prognosis and high recurrence. This study used an integrated...

Nazia Zarin, Tasnim Hosen Tanha, Mimuna Nishad et al. · 0 citations
Open access Aug 2026

Integrated Transcriptomic and Immune Landscape Profiling Identifies CXCR2 and IL1RN as Key Immune-Related Downregulated Genes in Oral Squamous Cell Carcinoma.

BACKGROUND Oral squamous cell carcinoma (OSCC) is among the most common head and neck cancers, representing about 90% of all cases. Despite advances in treatment, the prognosis remains poor, mainly owing to the complex immunosuppressive tumor microenvironment. METHODS The GEO2R tool was used to screen differentially...

Mohammad Hossin Shushizadeh, Niloufar Sadat Kalaki, Tahmineh Mohammadi Chamardani et al. · 0 citations
Aug 2026

Resveratrol Modulates Lung Cancer-Associated Hub Genes Identified by Integrated Bioinformatics, Single-Cell Analysis, Molecular Docking, and Experimental Validation

This study identified five lung cancer-associated hub genes and provided preliminary evidence that resveratrol may modulate their expression, and provides a multi-level molecular framework for further investigation of resveratrol-responsive networks in lung cancer.

Jing-Hua Yang, Han-Xiu Wei, Jie Li et al. · 0 citations
Open access 2021

Bioinformatics enriched analysis for identification of novel candidate genes and pathways for cystic fibrosis

Cystic Fibrosis, an inherited disorder, is primarily found in white American society. It arises due to alteration in the CFTR gene. Several pieces of evidence insight oxidative stress as one of the primary reasons behind this disorder. Thus, with the aim of finding the physiopathology of this disorder and its associati...

Aurobinda Das, Suresh Kumar Panda, Debakanta Sahoo · 0 citations
Aug 2026

Comprehensive bioinformatics analysis identifies candidate ciliogenesis-related genes preferentially associated with N0-stage lung squamous cell carcinoma.

PURPOSE There is few research on which genes play an important role in tumors without lymph metastasis. This study aimed to identify candidate molecular alterations preferentially associated with N0-stage LUSC. METHODS we conducted a comprehensive bioinformatics analysis using publicly available The Cancer Genome Atl...

Marzyeh Alipour, M. Moghanibashi, S. Naeimi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.